Company
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
67 Case(s) (Last 5 Years)
Patents Prosecuted
| Application number | Title of the patent | IPC | Filing Date | Decision Date |
|---|---|---|---|---|
| 17870165 | Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors | C07D | Jul 20, 2022 | |
| 17870151 | 5-oxo-1,2,3,5,8,8a-hexahydroindolizine-3-carboxamide Derivatives Useful As a Factor XIa Inhibitors | C07D | Jul 20, 2022 | |
| 17870142 | Substituted 1,2,3,8,9,9a-hexahydro-5H-pyrrolo[1,2-a]azepin-5-ones as factor XIa inhibitors | C07D, A61K | Jul 20, 2022 | Apr 15, 2024 |
| 17870156 | Bicyclic Pyridin-2-one and pyrimidin-4-one Derivatives Useful As a Factor XIa Inhibitors | C07D | Jul 20, 2022 | |
| 17854801 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHODS OF THEIR USE | A61K | Jun 29, 2022 | |
| 17736305 | Formulations/Compositions Comprising a BTK Inhibitor | A61P, A61K | May 3, 2022 | |
| 17732724 | 7,8-dihydrobenzo[e]pyrido[3,4-c]azocine-2,5(3H,6H)-dione derivatives useful as a factor XIa inhibitors | C07D | Apr 28, 2022 | Feb 12, 2024 |
| 17719607 | PROCESSES AND INTERMEDIATES FOR PREPARING A BTK INHIBITOR | C07D | Apr 12, 2022 | |
| 17711277 | Esketamine for the treatment of depression | A61P, A61K | Mar 31, 2022 | Jan 29, 2024 |
| 17710116 | Production of E. coli O18 Bioconjugates | C12N, A61K, A61P | Mar 30, 2022 | |
| 17705225 | INHIBITORS OF BRUTON'S TYROSINE KINASE AND METHOD OF THEIR USE | C07D | Mar 24, 2022 | |
| 17696925 | Bicyclic pyridine N-oxide derivatives useful as a factor XIa inhibitors | A61K, C07D | Mar 16, 2022 | Dec 18, 2023 |
| 17696922 | Substituted pyridine N-oxide derivatives useful as a factor XIa inhibitors | C07D | Mar 16, 2022 | Mar 4, 2024 |
| 17690380 | SMALL MOLECULE INHIBITOR OF THE JAK FAMILY OF KINASES | A61P, A61K, C12Q | Mar 8, 2022 | |
| 17688004 | PRE-FILLED SYRINGE WITH OPTIMIZED STOPPER PLACEMENT | A61K, A61M | Mar 6, 2022 | |
| 18548739 | 4-ALKOXY-6-OXO-PYRIDAZINE DERIVATIVES MODULATING NLRP3 | C07D, A61K, A61P | Mar 2, 2022 | |
| 17683470 | COMBINATION THERAPY USING A MALT1 INHIBITOR AND A BTK INHIBITOR | A61K | Feb 28, 2022 | |
| 17672123 | TRISPECIFIC ANTIBODY TARGETING BCMA, GPRC5D, AND CD3 | A61P, C07K | Feb 14, 2022 | |
| 17670123 | Compositions And Methods For The Treatment Of Depression | A61K, A61P | Feb 10, 2022 | |
| 17648750 | RAPAMYCIN ANALOGS AND USES THEREOF | C07D | Jan 23, 2022 |